 | • レポートコード：MRC2-11QY12069 • 出版社/出版日：QYResearch / 2020年11月25日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、91ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：ヘルスケア |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥877,500 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,170,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は痛風治療薬のグローバル市場について調査・分析したレポートです。種類別（NSAID、コルチコステロイド、コルヒチン、尿酸低下薬）市場規模、用途別（急性痛風、慢性痛風）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別痛風治療薬の競争状況、市場シェア ・世界の痛風治療薬市場：種類別市場規模 2015年-2020年（NSAID、コルチコステロイド、コルヒチン、尿酸低下薬） ・世界の痛風治療薬市場：種類別市場規模予測 2021年-2026年（NSAID、コルチコステロイド、コルヒチン、尿酸低下薬） ・世界の痛風治療薬市場：用途別市場規模 2015年-2020年（急性痛風、慢性痛風） ・世界の痛風治療薬市場：用途別市場規模予測 2021年-2026年（急性痛風、慢性痛風） ・北米の痛風治療薬市場分析：米国、カナダ ・ヨーロッパの痛風治療薬市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの痛風治療薬市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の痛風治療薬市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの痛風治療薬市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Takeda Pharmaceutical Company、Novartis、AstraZeneca、GlaxoSmithKline、Merck、Regeneron Pharmaceuticals ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Gout is a physical conditions that affects the patient’s ability to move, often also termed as unwalkable disease, and it has been around for centuries.
Increased research and development in the field has yielded significantly more effective medications in the recent times, which are recommended to patients on the basis of severity of the condition. Introduction of urate-lowering agents is one of the primary driver of the gout therapeutics market. First line therapies such as Febuxostat and Allopurinol are now replaced urate-lowering agents such as Lesinurad, which help in reducing pain as well as negotiate the risk of joint destruction. The growing popularity of OTC drugs such as Oral colchicine, corticosteroids, and NASAIDs, which are quite effective in moderate gout indications, are also favoring the global gout therapeutics market in the positive direction. Technological advancements in medical imaging is another factor augmenting the demand in the gout therapeutics market. On the other hand, low levels of physician and patient awareness, heavy dependency on generic drugs, and use of CAM for the treatment of gout are restraining factors over the global gout therapeutics market.
Market Analysis and Insights: Global Gout Therapeutics Market
The global Gout Therapeutics market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Gout Therapeutics Scope and Market Size
Gout Therapeutics market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Gout Therapeutics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The key players covered in this study
Takeda Pharmaceutical Company
Novartis
AstraZeneca
GlaxoSmithKline
Merck
Regeneron Pharmaceuticals
…
Market segment by Type, the product can be split into
NSAIDs
Corticosteroids
Colchicine
Urate-Lowering Agents
Market segment by Application, split into
Acute Gout
Chronic Gout
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Gout Therapeutics Revenue
1.4 Market by Type
1.4.1 Global Gout Therapeutics Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 NSAIDs
1.4.3 Corticosteroids
1.4.4 Colchicine
1.4.5 Urate-Lowering Agents
1.5 Market by Application
1.5.1 Global Gout Therapeutics Market Share by Application: 2020 VS 2026
1.5.2 Acute Gout
1.5.3 Chronic Gout
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Gout Therapeutics Market Perspective (2015-2026)
2.2 Global Gout Therapeutics Growth Trends by Regions
2.2.1 Gout Therapeutics Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Gout Therapeutics Historic Market Share by Regions (2015-2020)
2.2.3 Gout Therapeutics Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Gout Therapeutics Market Growth Strategy
2.3.6 Primary Interviews with Key Gout Therapeutics Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Gout Therapeutics Players by Market Size
3.1.1 Global Top Gout Therapeutics Players by Revenue (2015-2020)
3.1.2 Global Gout Therapeutics Revenue Market Share by Players (2015-2020)
3.1.3 Global Gout Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Gout Therapeutics Market Concentration Ratio
3.2.1 Global Gout Therapeutics Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Gout Therapeutics Revenue in 2019
3.3 Gout Therapeutics Key Players Head office and Area Served
3.4 Key Players Gout Therapeutics Product Solution and Service
3.5 Date of Enter into Gout Therapeutics Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Gout Therapeutics Historic Market Size by Type (2015-2020)
4.2 Global Gout Therapeutics Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global Gout Therapeutics Market Size by Application (2015-2020)
5.2 Global Gout Therapeutics Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Gout Therapeutics Market Size (2015-2020)
6.2 Gout Therapeutics Key Players in North America (2019-2020)
6.3 North America Gout Therapeutics Market Size by Type (2015-2020)
6.4 North America Gout Therapeutics Market Size by Application (2015-2020)
7 Europe
7.1 Europe Gout Therapeutics Market Size (2015-2020)
7.2 Gout Therapeutics Key Players in Europe (2019-2020)
7.3 Europe Gout Therapeutics Market Size by Type (2015-2020)
7.4 Europe Gout Therapeutics Market Size by Application (2015-2020)
8 China
8.1 China Gout Therapeutics Market Size (2015-2020)
8.2 Gout Therapeutics Key Players in China (2019-2020)
8.3 China Gout Therapeutics Market Size by Type (2015-2020)
8.4 China Gout Therapeutics Market Size by Application (2015-2020)
9 Japan
9.1 Japan Gout Therapeutics Market Size (2015-2020)
9.2 Gout Therapeutics Key Players in Japan (2019-2020)
9.3 Japan Gout Therapeutics Market Size by Type (2015-2020)
9.4 Japan Gout Therapeutics Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Gout Therapeutics Market Size (2015-2020)
10.2 Gout Therapeutics Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Gout Therapeutics Market Size by Type (2015-2020)
10.4 Southeast Asia Gout Therapeutics Market Size by Application (2015-2020)
11 India
11.1 India Gout Therapeutics Market Size (2015-2020)
11.2 Gout Therapeutics Key Players in India (2019-2020)
11.3 India Gout Therapeutics Market Size by Type (2015-2020)
11.4 India Gout Therapeutics Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Gout Therapeutics Market Size (2015-2020)
12.2 Gout Therapeutics Key Players in Central & South America (2019-2020)
12.3 Central & South America Gout Therapeutics Market Size by Type (2015-2020)
12.4 Central & South America Gout Therapeutics Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 Takeda Pharmaceutical Company
13.1.1 Takeda Pharmaceutical Company Company Details
13.1.2 Takeda Pharmaceutical Company Business Overview
13.1.3 Takeda Pharmaceutical Company Gout Therapeutics Introduction
13.1.4 Takeda Pharmaceutical Company Revenue in Gout Therapeutics Business (2015-2020))
13.1.5 Takeda Pharmaceutical Company Recent Development
13.2 Novartis
13.2.1 Novartis Company Details
13.2.2 Novartis Business Overview
13.2.3 Novartis Gout Therapeutics Introduction
13.2.4 Novartis Revenue in Gout Therapeutics Business (2015-2020)
13.2.5 Novartis Recent Development
13.3 AstraZeneca
13.3.1 AstraZeneca Company Details
13.3.2 AstraZeneca Business Overview
13.3.3 AstraZeneca Gout Therapeutics Introduction
13.3.4 AstraZeneca Revenue in Gout Therapeutics Business (2015-2020)
13.3.5 AstraZeneca Recent Development
13.4 GlaxoSmithKline
13.4.1 GlaxoSmithKline Company Details
13.4.2 GlaxoSmithKline Business Overview
13.4.3 GlaxoSmithKline Gout Therapeutics Introduction
13.4.4 GlaxoSmithKline Revenue in Gout Therapeutics Business (2015-2020)
13.4.5 GlaxoSmithKline Recent Development
13.5 Merck
13.5.1 Merck Company Details
13.5.2 Merck Business Overview
13.5.3 Merck Gout Therapeutics Introduction
13.5.4 Merck Revenue in Gout Therapeutics Business (2015-2020)
13.5.5 Merck Recent Development
13.6 Regeneron Pharmaceuticals
13.6.1 Regeneron Pharmaceuticals Company Details
13.6.2 Regeneron Pharmaceuticals Business Overview
13.6.3 Regeneron Pharmaceuticals Gout Therapeutics Introduction
13.6.4 Regeneron Pharmaceuticals Revenue in Gout Therapeutics Business (2015-2020)
13.6.5 Regeneron Pharmaceuticals Recent Development
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
Table 1. Gout Therapeutics Key Market Segments
Table 2. Key Players Covered: Ranking by Gout Therapeutics Revenue
Table 3. Ranking of Global Top Gout Therapeutics Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Gout Therapeutics Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of NSAIDs
Table 6. Key Players of Corticosteroids
Table 7. Key Players of Colchicine
Table 8. Key Players of Urate-Lowering Agents
Table 9. Global Gout Therapeutics Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 10. Global Gout Therapeutics Market Size by Regions (US$ Million): 2020 VS 2026
Table 11. Global Gout Therapeutics Market Size by Regions (2015-2020) (US$ Million)
Table 12. Global Gout Therapeutics Market Share by Regions (2015-2020)
Table 13. Global Gout Therapeutics Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 14. Global Gout Therapeutics Market Share by Regions (2021-2026)
Table 15. Market Top Trends
Table 16. Key Drivers: Impact Analysis
Table 17. Key Challenges
Table 18. Gout Therapeutics Market Growth Strategy
Table 19. Main Points Interviewed from Key Gout Therapeutics Players
Table 20. Global Gout Therapeutics Revenue by Players (2015-2020) (Million US$)
Table 21. Global Gout Therapeutics Market Share by Players (2015-2020)
Table 22. Global Top Gout Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Gout Therapeutics as of 2019)
Table 23. Global Gout Therapeutics by Players Market Concentration Ratio (CR5 and HHI)
Table 24. Key Players Headquarters and Area Served
Table 25. Key Players Gout Therapeutics Product Solution and Service
Table 26. Date of Enter into Gout Therapeutics Market
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Gout Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 29. Global Gout Therapeutics Market Size Share by Type (2015-2020)
Table 30. Global Gout Therapeutics Revenue Market Share by Type (2021-2026)
Table 31. Global Gout Therapeutics Market Size Share by Application (2015-2020)
Table 32. Global Gout Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 33. Global Gout Therapeutics Market Size Share by Application (2021-2026)
Table 34. North America Key Players Gout Therapeutics Revenue (2019-2020) (Million US$)
Table 35. North America Key Players Gout Therapeutics Market Share (2019-2020)
Table 36. North America Gout Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 37. North America Gout Therapeutics Market Share by Type (2015-2020)
Table 38. North America Gout Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 39. North America Gout Therapeutics Market Share by Application (2015-2020)
Table 40. Europe Key Players Gout Therapeutics Revenue (2019-2020) (Million US$)
Table 41. Europe Key Players Gout Therapeutics Market Share (2019-2020)
Table 42. Europe Gout Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 43. Europe Gout Therapeutics Market Share by Type (2015-2020)
Table 44. Europe Gout Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 45. Europe Gout Therapeutics Market Share by Application (2015-2020)
Table 46. China Key Players Gout Therapeutics Revenue (2019-2020) (Million US$)
Table 47. China Key Players Gout Therapeutics Market Share (2019-2020)
Table 48. China Gout Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 49. China Gout Therapeutics Market Share by Type (2015-2020)
Table 50. China Gout Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 51. China Gout Therapeutics Market Share by Application (2015-2020)
Table 52. Japan Key Players Gout Therapeutics Revenue (2019-2020) (Million US$)
Table 53. Japan Key Players Gout Therapeutics Market Share (2019-2020)
Table 54. Japan Gout Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 55. Japan Gout Therapeutics Market Share by Type (2015-2020)
Table 56. Japan Gout Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 57. Japan Gout Therapeutics Market Share by Application (2015-2020)
Table 58. Southeast Asia Key Players Gout Therapeutics Revenue (2019-2020) (Million US$)
Table 59. Southeast Asia Key Players Gout Therapeutics Market Share (2019-2020)
Table 60. Southeast Asia Gout Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 61. Southeast Asia Gout Therapeutics Market Share by Type (2015-2020)
Table 62. Southeast Asia Gout Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 63. Southeast Asia Gout Therapeutics Market Share by Application (2015-2020)
Table 64. India Key Players Gout Therapeutics Revenue (2019-2020) (Million US$)
Table 65. India Key Players Gout Therapeutics Market Share (2019-2020)
Table 66. India Gout Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 67. India Gout Therapeutics Market Share by Type (2015-2020)
Table 68. India Gout Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 69. India Gout Therapeutics Market Share by Application (2015-2020)
Table 70. Central & South America Key Players Gout Therapeutics Revenue (2019-2020) (Million US$)
Table 71. Central & South America Key Players Gout Therapeutics Market Share (2019-2020)
Table 72. Central & South America Gout Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 73. Central & South America Gout Therapeutics Market Share by Type (2015-2020)
Table 74. Central & South America Gout Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 75. Central & South America Gout Therapeutics Market Share by Application (2015-2020)
Table 76. Takeda Pharmaceutical Company Company Details
Table 77. Takeda Pharmaceutical Company Business Overview
Table 78. Takeda Pharmaceutical Company Product
Table 79. Takeda Pharmaceutical Company Revenue in Gout Therapeutics Business (2015-2020) (Million US$)
Table 80. Takeda Pharmaceutical Company Recent Development
Table 81. Novartis Company Details
Table 82. Novartis Business Overview
Table 83. Novartis Product
Table 84. Novartis Revenue in Gout Therapeutics Business (2015-2020) (Million US$)
Table 85. Novartis Recent Development
Table 86. AstraZeneca Company Details
Table 87. AstraZeneca Business Overview
Table 88. AstraZeneca Product
Table 89. AstraZeneca Revenue in Gout Therapeutics Business (2015-2020) (Million US$)
Table 90. AstraZeneca Recent Development
Table 91. GlaxoSmithKline Company Details
Table 92. GlaxoSmithKline Business Overview
Table 93. GlaxoSmithKline Product
Table 94. GlaxoSmithKline Revenue in Gout Therapeutics Business (2015-2020) (Million US$)
Table 95. GlaxoSmithKline Recent Development
Table 96. Merck Company Details
Table 97. Merck Business Overview
Table 98. Merck Product
Table 99. Merck Revenue in Gout Therapeutics Business (2015-2020) (Million US$)
Table 100. Merck Recent Development
Table 101. Regeneron Pharmaceuticals Company Details
Table 102. Regeneron Pharmaceuticals Business Overview
Table 103. Regeneron Pharmaceuticals Product
Table 104. Regeneron Pharmaceuticals Revenue in Gout Therapeutics Business (2015-2020) (Million US$)
Table 105. Regeneron Pharmaceuticals Recent Development
Table 106. Research Programs/Design for This Report
Table 107. Key Data Information from Secondary Sources
Table 108. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Gout Therapeutics Market Share by Type: 2020 VS 2026
Figure 2. NSAIDs Features
Figure 3. Corticosteroids Features
Figure 4. Colchicine Features
Figure 5. Urate-Lowering Agents Features
Figure 6. Global Gout Therapeutics Market Share by Application: 2020 VS 2026
Figure 7. Acute Gout Case Studies
Figure 8. Chronic Gout Case Studies
Figure 9. Gout Therapeutics Report Years Considered
Figure 10. Global Gout Therapeutics Market Size YoY Growth 2015-2026 (US$ Million)
Figure 11. Global Gout Therapeutics Market Share by Regions: 2020 VS 2026
Figure 12. Global Gout Therapeutics Market Share by Regions (2021-2026)
Figure 13. Porter's Five Forces Analysis
Figure 14. Global Gout Therapeutics Market Share by Players in 2019
Figure 15. Global Top Gout Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Gout Therapeutics as of 2019
Figure 16. The Top 10 and 5 Players Market Share by Gout Therapeutics Revenue in 2019
Figure 17. North America Gout Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 18. Europe Gout Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. China Gout Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Japan Gout Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Southeast Asia Gout Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. India Gout Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Central & South America Gout Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Bottom-up and Top-down Approaches for This Report
Figure 25. Data Triangulation
Figure 26. Key Executives Interviewed
痛風疾患治療の世界市場（～2026年） Gout is a disease characterized by recurrent attacks of acute inflammatory arthritis. The increase in the number of gout disease incidences and strong development of the treatment are some of the major factors driving the global gout disease treatment market. Improvised study on gout therapeutics an…- リウマチ治療の世界市場（～2026年） A rising elderly population and increasing allocations for research and development of new drugs is what is serving to drive growth in the global rheumatology therapeutics market. The global rheumatology therapeutics market will rise at a lackluster CAGR of 2.7% from 2017 to 2025. Market Analysis an…
- 急性腎不全治療薬の世界市場（～2026年） Acute renal failure is a sudden loss of kidney’s ability to eliminate excess fluids, salts and metabolic waste from the body. It leads to accumulation of metabolic waste and electrolytes in the body which can be life-threatening. Kidney eliminates creatinine (Metabolic waste) from the body. Acute re…
- 急性虚血性脳卒中治療薬の世界市場（～2026年） AIS is a chronic condition characterized by the sudden loss of blood supply to a part of the brain, thus causing subsequent loss of neurological function. AIS is caused by thrombotic or embolic obstruction of the cerebral artery and is more common than hemorrhagic stroke. The global AIS therapeutics…
- 慢性尋常性乾癬治療薬の世界市場（～2026年） Psoriasis is an autoimmune disease which is characterized by scaly patches of skin with inflammation and causes excessive production of new skin cells. Presently, there are no long term therapeutics available for the treatment of psoriasis. Chronic Plaque psoriasis is the one of the most common type…